SCHEMBL6662761

SCHEMBL6662761

O=C(O)c1cc(Cl)ccc1-c1ccc(/C=C/c2cc(C(F)(F)F)nc(=O)[nH]2)o1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.70
▸ KMT2A Q03164 5/20 0.70
▸ KDM4E B2RXH2 5/20 0.70
▸ ALDH1A1 P00352 3/20 0.70
▸ USP2 O75604 2/20 0.70
▸ L3MBTL1 Q9Y468 2/20 0.70
▸ CRHBP P24387 1/20 0.70
▸ CRHR2 Q13324 1/20 0.70
▸ POLB P06746 5/20 0.55
▸ HTT P42858 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ TLR9 Q9NR96 1/20 0.55
▸ PSD A5PKW4 1/20 0.45
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ CTSB P07858 2/20 0.38
▸ KLKB1 P03952 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662764 1.00 MEN1 (0.70) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6598777 0.83 MEN1 (1.00) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6598781 0.83 MEN1 (1.00) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL16211019 0.80 PSD (0.55) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL16211020 0.80 PSD (0.55) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6684366 0.79 KMT2A (0.46) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6664657 0.78 MEN1 (0.50) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6664624 0.77 PSD (0.52) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6594511 0.76 MEN1 (0.88) MEN1KMT2AKDM4EALDH1A1USP2
SCHEMBL6594515 0.76 MEN1 (0.88) MEN1KMT2AKDM4EALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 — — WO disclosed
Send feedback